Patents by Inventor Benjamin Mayes

Benjamin Mayes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260014194
    Abstract: The present disclosure provides pharmaceutical combinations comprising MetAP2 inhibitors for the treatment of cancer.
    Type: Application
    Filed: March 16, 2023
    Publication date: January 15, 2026
    Inventors: Bradley J. CARVER, James SHANAHAN, Peter CORNELIUS, Benjamin MAYES
  • Publication number: 20150224085
    Abstract: Provided herein are methods of administering a 5,5-fused heteroarylene hepatitis C virus inhibitor compound or an isotopic variant thereof, or a pharmaceutically acceptable salt or solvate thereof; for treating or preventing hepatitis C virus infection in a subject.
    Type: Application
    Filed: August 29, 2013
    Publication date: August 13, 2015
    Applicant: Indenix Pharmaceuticals, Inc
    Inventors: Rahela Gasparac, Benjamin Mayes, Adel Moussa, Keith Piet-Ropaolo, John Sullivan-Bolyai, Xiao-Jian Zhou
  • Publication number: 20070203334
    Abstract: A process is provided for the preparation of a key intermediate in the preparation of 2?-branched nucleoside compounds. The process includes contacting a protected precursor 3,4-O-isopropylidene-2-C-substituted-D-arabinono-1,5-lactone with a fluorinating agent under anhydrous conditions and converting the precursor into a protected 2-deoxy-2-halo-2-C-disubstituted ribono-1,5-lactone and optionally into a 2-deoxy-2-halo-2-C-disubstituted ribono-1,4-lactone.
    Type: Application
    Filed: December 22, 2006
    Publication date: August 30, 2007
    Inventors: Benjamin Mayes, Adel Moussa